Skip to main content

AN 795 (Imatinib Mesylate 400 mg)

Pill with imprint AN 795 is Brown, Elliptical/Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Amneal Pharmaceuticals LLC.

Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 795

Imatinib mesylate 400 mg AN 795

Imatinib Mesylate

AN 795
400 mg
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Related images for "AN 795"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.